Calcific Aortic Valve Disease
📧 Sign up to get email alerts when something new happens for Calcific Aortic Valve Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS) [Phase 2, Phase 3]
A Phase 2/3 study of evogliptin (DA-1229) for calcific aortic valve disease with mild-to-moderate aortic stenosis has been suspended.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD [Phase 2]
Phase 2 clinical trial evaluating DA-1229 for efficacy and safety in calcific aortic valve disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD [Phase 4]
A randomized, open-label Phase 4 trial evaluating the inhibitory effect of evogliptin on progression of calcific aortic valve disease (CAVD)…